Nadeem Q. Mirza is Chief Medical Officer of Aprea Therapeutics, Inc.. Currently has a direct ownership of 6,730 shares of APRE, which is worth approximately $21,132. The most recent transaction as insider was on May 01, 2024, when has been sold 6,730 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.73K
0% 3M change
n/a 12M change
Total Value Held $21,132

Nadeem Q. Mirza Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 01 2024
BUY
Grant, award, or other acquisition
-
6,730 Added 50.0%
6,730 Common Stock
NQM

Nadeem Q. Mirza

Chief Medical Officer
Doylestown, PA

Track Institutional and Insider Activities on APRE

Follow Aprea Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APRE shares.

Notify only if

Insider Trading

Get notified when an Aprea Therapeutics, Inc. insider buys or sells APRE shares.

Notify only if

News

Receive news related to Aprea Therapeutics, Inc.

Track Activities on APRE